Covered medications
175+ covered medications
Search Leap's covered medications by medication name or condition. Your Care Guide can confirm what is available through your specific benefits.
A
| Drug name | Condition |
|---|---|
| Actemra | Rheumatoid arthritis, giant cell arteritis, cytokine release syndrome |
| Adakveo | Sickle cell disease (vaso-occlusive crises) |
| Adcetris | Hodgkin lymphoma, systemic ALCL |
| Advate | Hemophilia A |
| Afstyla | Hemophilia A |
| Ajovy | Migraine prevention |
| Aldurazyme | Mucopolysaccharidosis I (MPS I) |
| Alprolix | Hemophilia B |
| Alymsys | Colorectal, lung, kidney cancers |
| Amondys 45 | Duchenne muscular dystrophy (exon 45 skipping) |
| Amvuttra | Hereditary transthyretin-mediated amyloidosis |
| Aralast NP | Alpha-1 antitrypsin deficiency |
| Aranesp | Anemia from CKD or chemotherapy |
| Asceniv | Primary humoral immunodeficiency |
| Avastin | Colorectal, lung, kidney, cervical cancers |
| Avsola | IBD, rheumatoid arthritis |
B
| Drug name | Condition |
|---|---|
| Bavencio | Merkel cell carcinoma, urothelial carcinoma |
| BeneFIX | Hemophilia B |
| Benlysta | Systemic lupus erythematosus (SLE) |
| Beyfortus | Prevention of RSV in infants |
| Bivigam | Primary humoral immunodeficiency |
| Briumvi | Relapsing multiple sclerosis |
C
| Drug name | Condition |
|---|---|
| Cablivi | Acquired thrombotic thrombocytopenic purpura (aTTP) |
| Cerezyme | Gaucher disease |
| Cinqair | Severe asthma with eosinophilia |
| Cosentyx | Moderate-to-severe plaque psoriasis, psoriatic arthritis |
| Crysvita | X-linked hypophosphatemia |
| Cuvitru | Primary immunodeficiency (subcutaneous) |
| Cyramza | Gastric, colorectal, lung, liver cancers |
D
| Drug name | Condition |
|---|---|
| Darzalex | Multiple myeloma |
| Darzalex Faspro | Multiple myeloma |
E
| Drug name | Condition |
|---|---|
| Elaprase | Mucopolysaccharidosis II (Hunter syndrome) |
| Elelyso | Gaucher disease type 1 |
| Elfabrio | Fabry disease |
| Eloctate | Hemophilia A |
| Elrexfio | Relapsed/refractory multiple myeloma |
| Empliciti | Multiple myeloma |
| Enhertu | HER2-positive breast cancer, gastric cancer |
| Entyvio | Crohn's disease, ulcerative colitis |
| Epkinly | Relapsed/refractory diffuse large B-cell lymphoma |
| Epogen | Anemia from CKD, dialysis |
| Erbitux | Colorectal cancer, head and neck squamous cell carcinoma |
| Esperoct | Hemophilia A |
| Evenity | Osteoporosis in postmenopausal women |
| Evkeeza | Homozygous familial hypercholesterolemia |
| Exondys 51 | Duchenne muscular dystrophy (exon 51 skipping) |
F
| Drug name | Condition |
|---|---|
| Fabrazyme | Fabry disease |
| Fasenra | Severe eosinophilic asthma |
| Flebogamma DIF | Primary immunodeficiency, ITP |
| Fulphila | Neutropenia prophylaxis |
G
| Drug name | Condition |
|---|---|
| GAMIFANT | Primary hemophagocytic lymphohistiocytosis |
| Gammagard Liquid | Primary immunodeficiency, multifocal motor neuropathy |
| Gamunex-C | Primary immunodeficiency, CIDP |
| Givlaari | Acute hepatic porphyria |
| Glassia | Alpha-1 antitrypsin deficiency |
| Granix | Neutropenia prophylaxis |
H
| Drug name | Condition |
|---|---|
| Hemlibra | Hemophilia A (prophylaxis) |
| Herceptin | HER2-positive breast cancer and gastric cancer |
| Herceptin Hylecta | HER2-positive breast cancer |
| Herzuma | HER2-positive breast cancer |
| Humira | Rheumatoid arthritis, Crohn's disease, plaque psoriasis, and others |
| Hympavzi | Hemophilia A or B |
| HyQvia | Primary immunodeficiency (facilitated subcutaneous) |
I
| Drug name | Condition |
|---|---|
| Idelvion | Hemophilia B |
| Ilaris | Systemic JIA, periodic fever syndromes, gout flares |
| Imdelltra | Extensive-stage small cell lung cancer |
| Imfinzi | Urothelial carcinoma, non-small cell lung cancer |
| Increlex | Growth failure due to IGF-1 deficiency |
| Inflectra | IBD, rheumatoid arthritis |
| Injectafer | Iron deficiency anemia |
J
| Drug name | Condition |
|---|---|
| Jemperli | Endometrial cancer |
K
| Drug name | Condition |
|---|---|
| Kadcyla | HER2-positive breast cancer |
| Kanjinti | HER2-positive breast cancer |
| Kanuma | Lysosomal acid lipase deficiency |
| Keytruda | Melanoma, lung cancer, various solid tumors |
| Kisunla | Early symptomatic Alzheimer's disease |
| Kovaltry | Hemophilia A |
| Krystexxa | Chronic gout refractory to conventional therapy |
L
| Drug name | Condition |
|---|---|
| Lamzede | Alpha-mannosidosis |
| Lemtrada | Relapsing-remitting multiple sclerosis |
| Leqembi | Early Alzheimer's disease |
| Leqvio | Primary hyperlipidemia with elevated LDL-C |
| Libtayo | Cutaneous squamous cell carcinoma, NSCLC |
| Lumizyme | Pompe disease (glycogen storage disease type II) |
| Lunsumio | Follicular lymphoma |
M
| Drug name | Condition |
|---|---|
| Margenza | HER2-positive metastatic breast cancer |
| Mepsevii | Mucopolysaccharidosis VII (Sly syndrome) |
| Mircera | Anemia from CKD |
| Monjuvi | Relapsed/refractory diffuse large B-cell lymphoma |
| Monoferric | Iron deficiency anemia |
| Mvasi | Colorectal, lung, kidney cancers |
N
| Drug name | Condition |
|---|---|
| Naglazyme | Mucopolysaccharidosis VI (MPS VI) |
| Neulasta | Neutropenia prophylaxis in chemotherapy |
| Neupogen | Neutropenia, stem cell mobilization |
| Nexviazyme | Late-onset Pompe disease |
| Nivestym | Neutropenia |
| Nplate | Immune thrombocytopenia (ITP) |
| Nucala | Severe asthma with eosinophilic phenotype |
| Nulojix | Prophylaxis of organ rejection in renal transplant |
| Nywiq | Spinal muscular atrophy (SMA) |
O
| Drug name | Condition |
|---|---|
| Ocrevus | Multiple sclerosis (relapsing and primary progressive) |
| Ocrevus Zunovo | Multiple sclerosis |
| Ogivri | HER2-positive breast cancer |
| Omvoh | Ulcerative colitis |
| Onpattro | Hereditary transthyretin-mediated amyloidosis |
| Ontruzant | HER2-positive breast cancer |
| Opdivo | Melanoma, lung cancer, renal cell carcinoma |
| Opdualag | Unresectable or metastatic melanoma |
| Orencia | Rheumatoid arthritis, psoriatic arthritis |
| Oxlumo | Primary hyperoxaluria type 1 |
P
| Drug name | Condition |
|---|---|
| Padcev | Locally advanced or metastatic urothelial cancer |
| Panzyga | Primary immunodeficiency, ITP, CIDP |
| Perjeta | HER2-positive breast cancer |
| Phesgo | HER2-positive breast cancer |
| Piasky | Paroxysmal nocturnal hemoglobinuria |
| Portrazza | Metastatic squamous non-small cell lung cancer |
| Privigen | Primary immunodeficiency, immune thrombocytopenic purpura |
| Prolastin-C | Alpha-1 antitrypsin deficiency |
R
| Drug name | Condition |
|---|---|
| Radicava | ALS (amyotrophic lateral sclerosis) |
| Rebinyn | Hemophilia B |
| Reblozyl | Anemia in beta-thalassemia, myelodysplastic syndromes |
| Releuko | Neutropenia |
| Renflexis | IBD, rheumatoid arthritis |
| Retacrit | Anemia from CKD or chemotherapy |
| Riabni | Non-Hodgkin lymphoma, rheumatoid arthritis |
| Rituxan | Rheumatoid arthritis, non-Hodgkin lymphoma, CLL, granulomatosis with polyangiitis |
| Rituxan Hycela | Non-Hodgkin lymphoma, CLL |
| Rixubis | Hemophilia B |
| Rolvedon | Febrile neutropenia prophylaxis |
| Ruxience | Non-Hodgkin lymphoma, rheumatoid arthritis |
| Rybrevant | Non-small cell lung cancer |
| Rylaze | Acute lymphoblastic leukemia |
| Rystiggo | Generalized myasthenia gravis |
S
| Drug name | Condition |
|---|---|
| Saphnelo | Systemic lupus erythematosus |
| Sarclisa | Multiple myeloma |
| Simponi Aria | Rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis |
| Skyrizi | Crohn's disease, ulcerative colitis, plaque psoriasis |
| Soliris | Paroxysmal nocturnal hemoglobinuria, atypical HUS, neuromyelitis optica |
| Spevigo | Generalized pustular psoriasis |
| Stelara | Crohn's disease, ulcerative colitis, plaque psoriasis |
| Stimufend | Neutropenia prophylaxis |
| Sylvant | Castleman disease |
T
| Drug name | Condition |
|---|---|
| Takhzyro | Hereditary angioedema |
| Talvey | Relapsed/refractory multiple myeloma |
| Tecentriq | Bladder cancer, lung cancer |
| Tecvayli | Relapsed/refractory multiple myeloma |
| Tepezza | Thyroid eye disease |
| Tevimbra | Esophageal squamous cell carcinoma |
| Tivdak | Recurrent or metastatic cervical cancer |
| Trazimera | HER2-positive breast cancer |
| Tremfya | Psoriatic arthritis, plaque psoriasis |
| Trodelvy | Triple-negative breast cancer, urothelial cancer |
| Truxima | Non-Hodgkin lymphoma, rheumatoid arthritis |
| Tysabri | Multiple sclerosis, Crohn's disease |
| Tzield | Delay of type 1 diabetes onset |
U
| Drug name | Condition |
|---|---|
| Udenyca | Neutropenia prophylaxis |
| Ultomiris | Paroxysmal nocturnal hemoglobinuria, atypical HUS, generalized myasthenia gravis |
| Uplizna | Neuromyelitis optica spectrum disorder |
V
| Drug name | Condition |
|---|---|
| Vegzelma | Colorectal, lung, kidney cancers |
| Velcade | Multiple myeloma, mantle cell lymphoma |
| Veletri | Pulmonary arterial hypertension |
| Veopoz | CD55-deficient protein-losing enteropathy |
| Viltepso | Duchenne muscular dystrophy (exon 53 skipping) |
| Vimizim | Mucopolysaccharidosis IVA (Morquio A) |
| VPRIV | Gaucher disease type 1 |
| Vyepti | Migraine prevention |
| Vyondys 53 | Duchenne muscular dystrophy (exon 53 skipping) |
| Vyvgart | Generalized myasthenia gravis |
| Vyvgart Hytrulo | Generalized myasthenia gravis |
X
| Drug name | Condition |
|---|---|
| Xenpozyme | Acid sphingomyelinase deficiency (ASMD) |
| Xgeva | Bone metastases, giant cell tumor of bone |
| Xolair | Allergic asthma, chronic urticaria, nasal polyps |
Y
| Drug name | Condition |
|---|---|
| Yervoy | Melanoma, renal cell carcinoma |
Z
| Drug name | Condition |
|---|---|
| Zarxio | Neutropenia |
| Zemaira | Alpha-1 antitrypsin deficiency |
| Zirabev | Colorectal, lung, kidney cancers |
| Zymfentra | Crohn's disease, ulcerative colitis |
| Zynlonta | Relapsed/refractory diffuse large B-cell lymphoma |
| Zynyz | Merkel cell carcinoma |
Ready to check coverage?
See if your medication is covered through your benefits.
Leap can confirm plan availability, coordinate prior authorization, and walk you through next steps.